| Description |
| Product Type |
Product Size |
| Tablets |
15'S |
| Product Company |
| Searle Pharma |
Paracetamol and Orphenadrine Citrate |
| Product Type |
Product Size |
| Tablet |
100'S |
| Product Company |
| Wilson Pharmaceuticals |
Orphenadrine citrate 35mg, paracetamol 450mg |
| Product Type |
Product Size |
| Injection |
5'S |
| Product Company |
| Brookes Pharmaceutical |
Diclofenac sodium 100mg
|
| Product Type |
Product Size |
| Capsules |
20'S |
| Product Company |
| Brookes Pharmaceutical |
Diclofenac sodium 100mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
AJM Pharmaceuticals |
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Aqvida |
|
| Content | Nuberol Forte® (Paracetamol 650 mg + Orphenadrine 50 mg) for the symptomatic management of the painful musculoskeletal disorders one tablet three times a day or as per physician discretion or as per severity of pain and treatment duration is 7-10 days. | Orphenadrine citrate is a skeletal muscle relaxant. It acts in the central nervous system to produce muscle relaxant effects. Paracetamol is used to treat or prevent pain and reduce fever. | A drug that is used to treat the symptoms of rheumatoid arthritis and is being studied in the prevention and treatment of some types of skin cancer. It blocks substances that cause inflammation and pain. It may also prevent the growth of new blood vessels that tumors need to grow.
| The Sustain Release tablet form of diclofenac is used to reduce pain, swelling (inflammation), and joint stiffness from arthritis. | Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. |
Reviews
There are no reviews yet.